|
Market Closed -
Other stock markets
|
Pre-market 19:01:21 | |||
| 107.61 USD | +0.13% |
|
108.08 | +0.43% |
| 07-17 | CVS Health Opens Pharmacy-Focused Location in Houston | MT |
| 07-17 | Cvs Health Unveils First Pharmacy-Focused Cvs Pharmacy Location in Houston | CI |
| Market Cap | 137B 120B 111B 102B 193B 13,224B 196B 1,326B 520B 6,469B 515B 504B 22,275B | P/E 2026 * |
17.2x | P/E 2027 * | 14.9x |
|---|---|---|---|---|---|
| Enterprise Value | 193B 169B 156B 144B 272B 18,606B 276B 1,866B 732B 9,101B 724B 709B 31,341B | EV / Sales 2026 * |
0.47x | EV / Sales 2027 * | 0.44x |
| Free-Float |
71.2% | Yield 2026 * |
2.47% | Yield 2027 * | 2.55% |
Last Transcript: CVS Health Corporation
| 1 day | +0.13% | ||
| 1 week | +3.32% | ||
| Current month | +4.02% | ||
| 1 month | +9.45% | ||
| 3 months | +39.21% | ||
| 6 months | +36.91% | ||
| Current year | +35.60% |
| 1 week | 103.56 |  | 108.97 |
| 1 month | 99 | | 108.97 |
| Current year | 69.51 | | 108.97 |
| 1 year | 58.5 | | 108.97 |
| 3 years | 43.56 | | 108.97 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
Ali Keshavarz
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/26/26 | Tax | Controller/Auditor | -454 | 0.0000% | ||
| 5/31/26 | Tax | Chief Technology Officer | -7,618 | 0.0006% | ||
| 5/31/26 | Tax | Chief Financial Officer | -2,478 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.13% | +3.32% | +73.68% | +44.68% | 137B | |
| -0.20% | -8.90% | +2.58% | +29.20% | 82.34B | |
| +3.04% | +1.01% | +5.16% | +62.69% | 26.9B | |
| -1.43% | +0.11% | +24.41% | +45.12% | 23.32B | |
| +0.61% | +0.23% | -15.10% | -28.90% | 19.94B | |
| -0.27% | -4.83% | +11.04% | +141.86% | 16.79B | |
| -0.92% | -0.31% | +7.36% | +6.26% | 15.38B | |
| -1.21% | +0.56% | +65.84% | +123.46% | 15.21B | |
| +0.07% | +0.81% | -7.99% | -13.15% | 12.84B | |
| +1.12% | -0.56% | -9.40% | +80.14% | 11.01B | |
| Average | +0.09% | -1.07% | +15.76% | +49.14% | 36.09B | |
| Weighted average by Cap. | +0.11% | -1.03% | +32.74% | +43.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 409B 359B 332B 305B 576B 39,481B 585B 3,959B 1,553B 19,313B 1,537B 1,504B 66,506B | 427B 374B 346B 318B 601B 41,149B 610B 4,126B 1,618B 20,129B 1,602B 1,567B 69,315B |
| Net income | 8.04B 7.05B 6.52B 5.99B 11.33B 776B 11.5B 77.8B 30.51B 380B 30.21B 29.55B 1,307B | 9.35B 8.19B 7.57B 6.96B 13.16B 901B 13.36B 90.38B 35.44B 441B 35.09B 34.33B 1,518B |
| Net Debt | 55.81B 48.91B 45.2B 41.58B 78.59B 5,382B 79.8B 540B 212B 2,633B 210B 205B 9,066B | 52.23B 45.78B 42.3B 38.91B 73.55B 5,037B 74.68B 505B 198B 2,464B 196B 192B 8,484B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-20 | US$107.61 | +0.13% | 6,506,870 |
| 26-07-17 | US$107.47 | +0.91% | 6,608,659 |
| 26-07-16 | US$106.50 | +0.56% | 12,025,143 |
| 26-07-15 | US$105.91 | -0.25% | 6,939,634 |
| 26-07-14 | US$106.18 | +0.26% | 11,396,143 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
